Insider trade

Officer sold ~$617K of ELV shares in the open market

Traded May 19, 2026 · Filed May 20, 2026

Elevance HealthELV

~$617K
Reported value · 1,531 sh @ $403.13: 4,109
Holds after · shares reported: -5.1%
stock since the trade · S&P 500 +4.1%, $402.27 → $381.67 on Oct 1

Why it stands out

Elevance Health's CAO & Controller sold $617K of Elevance Health shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 19, 2026
Reporting period: Not applicable
Filed with the SEC: May 20, 2026

Officer$500K–$1M

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$617,192

Shares × reported transaction price

Timing vs results

27 days after results of Apr 22, 2026, 57 days before results of Jul 15, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $402.27 on May 19, 2026, within 3% of its 52-week high, after a 29% rise over the previous 30 trading days

52-week range $274.66 (Aug 1, 2025) to $412.49 (May 20, 2025), 93% of the way up, from 251 adjusted closes. 30 trading days earlier: $311.83 on Apr 7, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.

MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	+0.8%	+1.6%	-0.8%
30 days	+1.3%	+0.2%	+1.1%
90 days	+2.2%	+3.5%	-1.3%

Past results only. Not a forecast.

Source receipt

Record ID: 0001659075-26-000004
Filed / recorded: May 20, 2026, 8:11 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Elevance Health, Inc.
Issuer CIK: 1156039
Ticker: ELV
Reporting person: Ronald W Penczek
Relationship: Officer
Officer title: CAO & Controller
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: May 19, 2026
Transaction code: S
Shares / units: 1,531
Price per share: $403.13
Acquired / disposed: Disposed (D)
Shares owned after: 4,109
Ownership form: Direct
Amendment: No

Footnotes from the filing

This transaction was executed in multiple trades, each at the same price of $403.13.

Around the same time

Officer sold4mo ago

~$149KReported value · 369 sh @ $403.16

Elevance Health's CAO & Controller sold $149K of Elevance Health shares. Nobody planned it ahead of time.

Why it stands out Official record

Director sold4mo ago

~$61KReported value · 151 sh @ $401.77

A board member of Elevance Health sold $61K of Elevance Health shares. Nobody planned it ahead of time.

Why it stands out Official record

5mo ago

654Shares · @ $271.27

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record